Injeq IQ-Tip system has been granted the Breakthrough Device designation by FDA!
The FDA’s Breakthrough Devices Program is designed to expedite the review of medical devices that offer significant advancements in treating or diagnosing life-threatening or debilitating conditions. The Breakthrough Devices designation is granted to devices that demonstrate the potential to offer substantial benefits over existing technologies.
The share issue of Injeq Plc. ended on April 5, 2024, and the investment round did not achieve the goals […]
Read more »
Injeq has started a share issue. The maximum of the financing round is set at €3,000,000. If the €2,000,000 goal […]
Read more »
Injeq webinar videos are now available! Welcome to participate in Dr. Sauli Palmu’s lecture “Lumbar punctures in pediatric hemato-oncology” (part […]
Read more »
We are pleased to announce that GENFAX is appointed as INJEQ’s exclusive distributor in Romania. We are confident that our […]
Read more »
Welcome to the webinar “Innovation in lumbar punctures” on February 22nd, 2024, at 7:00 pm (Madrid time Zone) Lecturers […]
Read more »
Join the webinar revealing the revolutionary technique of lumbar punctures for healthcare professionals. Discover the innovative technology behind Injeq IQ-Tip®, […]
Read more »